A Phase III, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of different schedules and formulations of a meningococcal A conjugate vaccine administered concomitantly with local EPI vaccines in healthy infants and toddlers.

Trial Profile

A Phase III, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of different schedules and formulations of a meningococcal A conjugate vaccine administered concomitantly with local EPI vaccines in healthy infants and toddlers.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Meningococcal vaccine group A conjugate (Primary)
  • Indications Meningococcal group A infections; Meningococcal meningitis
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 16 Jan 2014 Status changed from active, no longer recruiting to completed (closed to recruitment: follow up complete) as reported by Pan-African Clinical Trials Registry record.
    • 24 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top